Stockholders Equity - Narrative (FY) (Details) $ / shares in Units, $ in Thousands |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3 Months Ended |
9 Months Ended |
12 Months Ended |
|
|
|
|
|
Sep. 15, 2024
USD ($)
$ / shares
shares
|
Mar. 04, 2024
USD ($)
$ / shares
shares
|
Jan. 12, 2024
USD ($)
$ / shares
shares
|
Nov. 09, 2023
USD ($)
$ / shares
shares
|
Nov. 08, 2023
shares
|
Oct. 04, 2023
USD ($)
|
Oct. 02, 2023
USD ($)
$ / shares
shares
|
Sep. 11, 2023
USD ($)
|
Sep. 07, 2023
USD ($)
$ / shares
shares
|
Aug. 22, 2023
$ / shares
shares
|
Feb. 27, 2023
USD ($)
|
Feb. 23, 2023
$ / shares
shares
|
Sep. 28, 2022
USD ($)
|
Aug. 13, 2021
$ / shares
shares
|
Aug. 12, 2021
USD ($)
$ / shares
shares
|
Jun. 30, 2021
USD ($)
|
Sep. 30, 2024
USD ($)
$ / shares
shares
|
Sep. 30, 2023
USD ($)
|
Mar. 31, 2023
USD ($)
|
Sep. 30, 2024
USD ($)
$ / shares
shares
|
Sep. 30, 2023
USD ($)
|
Dec. 31, 2023
USD ($)
$ / shares
shares
|
Dec. 31, 2022
USD ($)
$ / shares
shares
|
Nov. 06, 2023
$ / shares
shares
|
Oct. 01, 2023 |
Sep. 10, 2023 |
Mar. 31, 2022
shares
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares of stock authorized (in shares) |
|
|
|
|
|
|
|
|
|
274,312,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, number of shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20,000,000
|
|
|
20,000,000
|
|
20,000,000
|
20,000,000
|
|
|
|
|
| Preferred stock, par value (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.00001
|
|
|
$ 0.00001
|
|
$ 0.00001
|
$ 0.00001
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
|
|
|
2,904,269
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
$ 0.96
|
$ 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term (years) |
|
5 years
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
5 years
|
|
5 years
|
|
|
|
|
|
| Proceeds from issuance of warrants | $ |
$ 2,400
|
$ 3,500
|
$ 3,600
|
$ 6,500
|
|
|
$ 3,600
|
|
$ 4,600
|
|
$ 9,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Offering fees and other expenses payable | $ |
|
|
|
$ 500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrants consideration (in dollars per share) | $ / shares |
|
|
|
$ 0.25
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Proceeds from exercise of warrants | $ |
|
|
|
$ 6,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 7,881
|
$ 0
|
|
|
|
|
| Shares issued upon exercise of warrant (in shares) |
|
|
|
|
1,188,269
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants outstanding (in shares) |
|
|
|
|
1,716,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate cost | $ |
2,800
|
4,000
|
4,000
|
|
|
|
4,000
|
|
5,000
|
|
10,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Agent fees and other offering costs | $ |
$ 300
|
$ 500
|
$ 400
|
|
|
|
$ 400
|
|
$ 400
|
|
700
|
|
|
|
|
|
|
|
|
$ 1,137
|
$ 1,135
|
2,048
|
0
|
|
|
|
|
| Equity related to warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 2,443
|
|
|
|
|
|
|
|
|
|
|
| Percentage of equity interest sold by co-founders |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
100.00%
|
|
|
|
|
|
|
|
|
|
|
|
| Additional payments owed to co-founders | $ |
|
|
|
|
|
|
|
|
|
|
10,000
|
|
|
|
|
$ 10,000
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum proceeds from sale of business and other capital raising transactions | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
250,000
|
|
|
|
|
|
|
|
|
|
|
|
| Additional funding received in connection with business combination | $ |
|
|
|
|
|
|
|
|
|
|
247,300
|
|
|
|
$ 247,300
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payment of liability | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10,000
|
|
|
|
|
|
|
|
|
| Change in fair value of warrant liability | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
$ (221)
|
|
$ 0
|
$ (559)
|
(561)
|
(5,185)
|
|
|
|
|
| Deferred offering costs | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
300
|
|
|
|
|
|
| ATM Sales Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate cost | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0
|
|
|
|
|
|
| Commission rate percentage |
|
|
|
|
|
|
|
|
|
|
|
|
3.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consideration From Funds Legally Available |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Additional payments owed to co-founders | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 40,000
|
|
|
|
|
|
|
|
|
|
|
|
| Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares sold (in shares) |
|
|
|
|
|
|
|
|
|
|
|
187,920
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 43.23
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate cost | $ |
|
|
|
|
|
|
|
|
|
|
$ 10,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| November Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,808,538
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 3.86
|
|
|
|
| Warrant term (years) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
| Series A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
|
|
|
|
|
|
672,948
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
672,948
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
$ 7.18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term (years) |
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 years 11 months 8 days
|
|
|
| February Class A Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
|
|
|
|
|
|
231,321
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
231,321
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
$ 7.18
|
|
|
|
|
$ 57.5
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term (years) |
|
|
|
|
|
|
|
5 years 3 days
|
|
|
|
5 years 6 months 3 days
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4 years 11 months 19 days
|
|
| Equity related to warrants | $ |
|
|
|
|
|
|
|
$ 600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| October Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
|
|
|
|
|
|
2,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,000,000
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
$ 2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term (years) |
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Estimated fair value of warrants | $ |
|
|
|
$ 500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Equity related to warrants | $ |
|
|
|
|
|
|
$ 1,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Prefunded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
|
|
|
|
|
|
1,710,000
|
|
462,948
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
$ 0.00001
|
|
$ 0.00001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Prefunded Warrants | Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
$ 0.00001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares sold (in shares) |
|
|
|
|
|
|
|
|
|
|
|
43,401
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Series B Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
|
|
|
|
|
|
672,948
|
|
672,948
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
$ 7.18
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term (years) |
|
|
|
|
|
|
|
|
1 year
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
11 months 12 days
|
|
|
| Proceeds from exercise of warrants | $ |
|
|
|
|
|
$ 1,300
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Public Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants outstanding (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
172,500
|
|
|
172,500
|
|
172,500
|
|
|
|
|
|
| Equity related to warrants | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 20,200
|
|
|
|
|
|
|
|
|
|
|
|
|
| Private Placement Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants outstanding (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
225,450
|
|
|
225,450
|
|
225,450
|
|
|
|
|
|
| Other Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5,563
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 10
|
|
|
|
|
|
| Number of warrants outstanding (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6,171
|
|
|
|
|
|
| Private Warrant |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Change in fair value of warrant liability | $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ (600)
|
$ (5,200)
|
|
|
|
|
| October Pre-Funded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1,710,000
|
|
|
|
|
|
| September Prefunded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
462,948
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
$ 0.00001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| February Prefunded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
43,401
|
|
|
|
|
|
| Common Class A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stock split ratio |
|
|
|
|
|
|
|
|
|
0.02
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, number of shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
250,000,000
|
|
|
|
|
|
|
250,000,000
|
|
|
250,000,000
|
|
250,000,000
|
250,000,000
|
|
|
|
|
| Common stock, par value (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.00001
|
|
|
|
|
|
|
$ 0.00001
|
|
|
$ 0.00001
|
|
$ 0.00001
|
$ 0.00001
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
10,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 575
|
|
|
$ 575
|
|
$ 575
|
|
|
|
|
|
| Number of shares sold (in shares) |
|
1,320,000
|
900,000
|
|
|
|
290,000
|
|
210,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Purchase price (in dollars per share) | $ / shares |
$ 0.55
|
$ 0.87
|
$ 1.09
|
|
|
|
$ 2
|
|
$ 7.43
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Class A | ATM Sales Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Aggregate cost | $ |
|
|
|
|
|
|
|
|
|
|
|
|
$ 50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Class A | Contingent Sponsor Earnout Shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of shares modified (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
28,750
|
28,750
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Class A | Contingent Sponsor Earnout Shares | Weighted Average Closing Price of $12.50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted-average closing sale price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 625
|
$ 625
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Class A | Contingent Sponsor Earnout Shares | Weighted Average Closing Price of $15.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted-average closing sale price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
750
|
750
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Class A | Contingent Sponsor Earnout Shares | Weighted Average Closing Price of $17.50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted-average closing sale price (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 875
|
$ 875
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Class A | Common Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued upon exercise of warrant (in shares) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3,577,217
|
5,563
|
|
|
|
|
| Common Class A | September Prefunded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Exercise price (in dollars per share) | $ / shares |
$ 0.575
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term (years) |
5 years 6 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Class B |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common stock, number of shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
4,312,500
|
|
|
|
|
|
|
4,312,500
|
|
|
4,312,500
|
|
4,312,500
|
4,312,500
|
|
|
|
|
| Common stock, par value (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.00001
|
|
|
|
|
|
|
$ 0.00001
|
|
|
$ 0.00001
|
|
$ 0.00001
|
$ 0.00001
|
|
|
|
|
| Number of warrants exercised on net basis (in shares) |
5,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Common Class B | September Prefunded Warrants |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Warrant term (years) |
1 year 6 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred Stock |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, number of shares authorized (in shares) |
|
|
|
|
|
|
|
|
|
20,000,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Preferred stock, par value (in dollars per share) | $ / shares |
|
|
|
|
|
|
|
|
|
$ 0.00001
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|